Dr. Christian Voitenleitner

Lead Gilead effort to run an siRNA based functional genomics screen to discover new host targets for HBV infection Progressed 3 HCV small molecule leads (Nucleoside inhibitors) into clinical development Lead IND-enabling studies Extensive experience with FDA report writing and submission Certified Project Management Professional since November 2015 Certification Program in Clinical Research Conduct and Management

Respsonsible for supporting global and regional Strategic Developement and Market Intelligence

-Lead virologist in a Phase I clinical trial of an HCV direct acting antiviral -Written and published all necessary reports and documentation for successful IND filing with the FDA -Responsible for responding to comments and questions from the FDA regarding the virology part of the trial -Setup collaborations with CROs -Co-leader for the pre-clinical backup program for the clincal asset

-Development of high-throughput cell-based assays -Development, construction and validation of viral test systems based on patient serum samples -Supervisor of one research assistant.

Research in the area of Virology and Cell Biology. Papillomavirus project to study the host cell factors involved in viral maintenance.

Research in the area of Molecular Biology and Biochemistry. Thesis: Cell cycle dependent regulation of the replication activity of DNA polymerase alpha-primase

Chemistry, Biochemistry, Thesis: Characterization of Cyclins and Cyclin-dependent Kinases